Kuros Biosciences Completes Phase II Trial Enrollment
Kuros completed enrollment in the STRUCTURE trial, investigating Fibrin-PTH (KUR-113) in single-level transforaminal lumbar interbody fusion....
Kuros completed enrollment in the STRUCTURE trial, investigating Fibrin-PTH (KUR-113) in single-level transforaminal lumbar interbody fusion....
Improvements to CERAMENT G antibiotic-eluting bone graft substitute have been made to increase ease of use and reduce environmental impact....
New Precise technology is designed to provide physicians with more options for custom platelet-rich plasma....
BIO-REIGN 3D provides an ideal microenvironment for cell proliferation and vascularization leading to regeneration of healthy bone. ...
LDGraft is a next-generation bone graft substitute for spinal fusion, with encapsulated rhBMP-2 for controlled and extended release....
OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries....
Studies suggest that tissue created in a lab to replace damaged knee cartilage is just as good as the current...
The company will begin a 30-patient pilot clinical trial with NB1 in spinal fusion patients in Australia later this year....
MONTAGE settable, resorbable bone putty received additional 510(k) clearances as bone void filler and cranial bone cement....
Tactoset is cleared by FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.